The purpose of this Funding Opportunity Announcement (FOA) is to support the development of new diagnostic technologies for tuberculosis (TB) drug susceptibility testing (DST), including point of care (POC) DST and companion diagnostics for new TB drugs.
Deadlines:
Letter of Intent Due Date(s): 30 days prior to the application due date
Application Due Date: July 08, 2022
RFA-AI-22-016 Expiration Date July 09, 2022
Application budgets are limited to no more than $500,000 in direct costs for any project year.
The scope of the proposed project should determine the project period. The maximum project period is 5 years.
